The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...
The Indianapolis-based drugmaker missed expectations on sales of two popular drugs, diabetes treatment Mounjaro and ...
LLY had $11.4 billion in revenue for the quarter (up 20% versus Q3 figures from last year), with a net income of $970 million ...
U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent ...
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...
US stock indexes are wavering following a strong profit report from Google’s parent company, while drops for Eli Lilly and ...
U.S. stock indexes are edging higher Wednesday following a strong profit report from Google's parent company, though drops for Eli Lilly and others are keeping Wall Street in check.
Drugmaker Eli Lilly and Co. (LLY), while reporting third-quarter adjusted earnings and revenues below market estimates, on Wednesday ...